መነሻ › ክሮኒክ ማይሎይድ ሉኬሚያ
በአሜሪካ ለክሮኒክ ማይሎይድ ሉኬሚያ ተሳታፊዎችን እየፈለጉ ያሉ ክሊኒካዊ ጥናቶች
ለክሮኒክ ማይሎይድ ሉኬሚያ የሚደረጉ 48 ጥናቶች በአሜሪካ ውስጥ ባሉ ቦታዎች ተሳታፊዎችን እየፈለጉ ነው።
በጣም ብዙ ጥናቶች ያሏቸው ከተሞች
- Houston, TX18 ጥናቶች
- Seattle, WA11 ጥናቶች
- New York City, NY11 ጥናቶች
- Birmingham, AL6 ጥናቶች
- Detroit, MI6 ጥናቶች
- Chicago, IL6 ጥናቶች
- Portland, OR6 ጥናቶች
- Philadelphia, PA6 ጥናቶች
- Baldwin Park, CA6 ጥናቶች
- Nashville, TN5 ጥናቶች
- Columbus, OH5 ጥናቶች
- Boston, MA5 ጥናቶች
- Atlanta, GA5 ጥናቶች
- Baltimore, MD5 ጥናቶች
- Milwaukee, WI5 ጥናቶች
- Durham, NC5 ጥናቶች
- Rochester, NY4 ጥናቶች
- Washington, DC4 ጥናቶች
- St. Louis, MO4 ጥናቶች
- Kansas City, MO4 ጥናቶች
- Mountain View, CA4 ጥናቶች
- Augusta, GA4 ጥናቶች
- Cincinnati, OH4 ጥናቶች
- Buffalo, NY3 ጥናቶች
- St. Petersburg, FL3 ጥናቶች
- Aurora, CO3 ጥናቶች
- Orange, CA3 ጥናቶች
- Ann Arbor, MI3 ጥናቶች
- Cleveland, OH3 ጥናቶች
- Sacramento, CA3 ጥናቶች
- Miami, FL3 ጥናቶች
- Salt Lake City, UT3 ጥናቶች
- Bridgeport, CT3 ጥናቶች
- Edison, NJ3 ጥናቶች
- Greenville, NC3 ጥናቶች
- Minneapolis, MN3 ጥናቶች
በክልል
- New Jersey4 ጥናቶች
- New York15 ጥናቶች
- North Carolina8 ጥናቶች
- Ohio9 ጥናቶች
- Oregon6 ጥናቶች
- Pennsylvania7 ጥናቶች
- Tennessee5 ጥናቶች
- Texas18 ጥናቶች
- Utah3 ጥናቶች
- Virginia4 ጥናቶች
- Washington11 ጥናቶች
- Wisconsin5 ጥናቶች
- ሚሺጋን7 ጥናቶች
- ሚኔሶታ4 ጥናቶች
- ሚዙሪ4 ጥናቶች
- ማሳቹሴትስ5 ጥናቶች
- ሜሪላንድ6 ጥናቶች
- ኒብራስካ3 ጥናቶች
- አላባማ6 ጥናቶች
- አሪዞና4 ጥናቶች
- ኢሊኖይ6 ጥናቶች
- ኢንዲያና3 ጥናቶች
- ከንታኪ3 ጥናቶች
- ካሊፎርኒያ10 ጥናቶች
- ካንሳስ5 ጥናቶች
- ኮሎራዶ4 ጥናቶች
- ዲስትሪክት ኦፍ ኮሎምቢያ3 ጥናቶች
- ጆርጂያ7 ጥናቶች
- ፍሎሪዳ7 ጥናቶች
በቅርብ ጊዜ የተዘመኑ ጥናቶች
Official study text (English)
Autologous T Cells Transduced With Retroviral Vectors Expressing TCRs for Participant-specific Neoantigens in Patients With Hematologic Malignancies
ተሳታዮችን በመፈለግ ላይደረጃ 1
እድሜ ከ18 እስከ 120 · ሁሉም ጾታዎች · የተሻሻለው በ2 ኦክቶ 2026 · NCT06904066Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናትጤናማ ተሳታዮች ይቀበላሉ
እድሜ ከ40 እስከ 75 · ሁሉም ጾታዎች · የተሻሻለው በ2 ኦክቶ 2026 · NCT05334069Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
እድሜ ከ0 እስከ 38 · ሁሉም ጾታዎች · የተሻሻለው በ1 ኦክቶ 2026 · NCT06131801Phase II Study Assessing the Efficacy and Toxicity of Olverembatinib Monotherapy in Patients With Chronic Myeloid Leukemia in Chronic Phase After Failing One Prior Therapy With a Second Generation Tyrosine Kinase Inhibitor or Asciminib
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ1 ኦክቶ 2026 · NCT06817720Study to Determine the Dose and Safety of Asciminib in Pediatric Patients With Chronic Myeloid Leukemia
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
እድሜ ከ1 እስከ 17 · ሁሉም ጾታዎች · የተሻሻለው በ25 ሴፕቴ 2026 · NCT04925479Phase II Study Assessing the Safety and Efficacy of Dasatinib in Combination With Ropeginterferon in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ25 ሴፕቴ 2026 · NCT07269470Phase II Study Assessing Efficacy and Safety of Asciminib in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase.
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ25 ሴፕቴ 2026 · NCT06236724Darzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific Antibodies
ተሳታዮችን በመፈለግ ላይየመጀመሪያ ደረጃ 1
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ24 ሴፕቴ 2026 · NCT06398457Edetate Calcium Disodium or Succimer in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing Chemotherapy
ተሳታዮችን በመፈለግ ላይደረጃ 1
እድሜ 1 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ18 ሴፕቴ 2026 · NCT03630991Ponatinib Hydrochloride as Second Line Therapy in Treating Patients With Chronic Myeloid Leukemia in Chronic Phase Resistant or Intolerant to Imatinib Mesylate, Dasatinib, or Nilotinib
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ16 ሴፕቴ 2026 · NCT01746836Study of Olverembatinib (HQP1351) in Patients With CML-CP
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ15 ሴፕቴ 2026 · NCT06423911Cord Blood Transplant in Adults With Blood Cancers
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ ከ21 እስከ 65 · ሁሉም ጾታዎች · የተሻሻለው በ11 ሴፕቴ 2026 · NCT05884333Study to Determine the Efficacy and Safety of Asciminib in Pediatric Patients With Ph+ CML-CP
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ ከ1 እስከ 18 · ሁሉም ጾታዎች · የተሻሻለው በ2 ሴፕቴ 2026 · NCT07354074Axatilimab With or Without Azacitidine for the Treatment of Patients With Advanced Phase Myeloproliferative Neoplasms, Myeloproliferative Neoplasm/Myelodysplastic Syndrome Overlap or High Risk Chronic Myelomonocytic Leukemia
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ27 ኦገስ 2026 · NCT06523556Ex Vivo Drug Sensitivity Testing and Multi-Omics Profiling
ተሳታዮችን በመፈለግ ላይደረጃ 1
1 Day – 21 Years · ሁሉም ጾታዎች · የተሻሻለው በ26 ኦገስ 2026 · NCT05857969Protocol Number: HJKC3-0003. Treatment Free Remission After Asciminib Based Therapy in Chronic Phase Chronic Myeloid Leukemia (CP-CML) Patients Who Relapsed After a Prior Attempt at TKI Discontinuation
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ25 ኦገስ 2026 · NCT04838041TACrolimus Targeted Immunosuppression Cessation in ALlogeneic HCT
ተሳታዮችን በመፈለግ ላይደረጃ 1
እድሜ ከ18 እስከ 80 · ሁሉም ጾታዎች · የተሻሻለው በ17 ኦገስ 2026 · NCT07302776Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With High-Risk Hematologic Diseases
ተሳታዮችን በመፈለግ ላይደረጃ 2
6 Months – 65 Years · ሁሉም ጾታዎች · የተሻሻለው በ22 ጁላይ 2026 · NCT06013423A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
ለሁሉም እድሜ · ሁሉም ጾታዎች · የተሻሻለው በ6 ጁላይ 2026 · NCT01351545Allo HSCT Using RIC and PTCy for Hematological Diseases
ተሳታዮችን በመፈለግ ላይደረጃ 2
እስከ እድሜ 75 · ሁሉም ጾታዎች · የተሻሻለው በ6 ጁላይ 2026 · NCT05805605Asciminib Roll-over Study
ተሳታዮችን በመፈለግ ላይደረጃ 4
እድሜ ከ7 እስከ 100 · ሁሉም ጾታዎች · የተሻሻለው በ6 ጁላይ 2026 · NCT04877522Registry of Older Patients With Cancer
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
እድሜ 65 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ29 ጁን 2026 · NCT01137825Myeloablative Allo HSCT With Related or Unrelated Donor for Heme Disorders
ተሳታዮችን በመፈለግ ላይደረጃ 2
እስከ እድሜ 60 · ሁሉም ጾታዎች · የተሻሻለው በ25 ጁን 2026 · NCT03314974Onvansertib for the Treatment of Recurrent or Refractory Chronic Myelomonocytic Leukemia and Myelodysplastic Syndrome/MPN Overlap Neoplasms
ተሳታዮችን በመፈለግ ላይደረጃ 1
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ22 ጁን 2026 · NCT05549661Impact of Targeted Therapy on Cancer-Related Cognitive Impairment
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናትጤናማ ተሳታዮች ይቀበላሉ
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ10 ጁን 2026 · NCT07638007ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ5 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።